Royal Society of Chemistry's flagship journal now free to access


The Royal Society of Chemistry (RSC) has announced that it will make its flagship journal Chemical Science free to access from the start of 2015. Chemical Science will be a gold open access journal, and operate in a similar way to other gold open access journals run by publishing houses such as the Public Library of Science or BioMed Central, charging authors a fee to have their manuscripts published – once they have been peer reviewed and accepted for publication.

Chemical Science will be free to access from January 2015, and author fees for publishing in the journal will be suspended until 2017. The outgoing UK science minister, David Willetts, applauded the move as a ‘bold step’, adding that the country was leading the way in giving publicly-funded research the widest possible audience.

Dominic Tildesley, president of the RSC, said: ‘I am delighted that my first public announcement since assuming the presidency of the Royal Society of Chemistry just last week is a momentous step forward in sharing chemical science knowledge worldwide. The Royal Society of Chemistry fully supports sustainable open access publishing, as indeed do I.’


Related Content

10 years ago: open access

21 August 2014 Flashback

news image

The start of a shift to new publishing models

Opening the doors of knowledge

1 April 2012 Feature

news image

Should all journal articles be free to access online?

Most Read

UC Davis chemist sentenced to four years over explosion

19 November 2014 News and Analysis

news image

Postdoc sentenced over attempt to make explosive device and reckless disposal of hazardous waste

Spanish fly

10 October 2013 Podcast | Compounds

news image

Helen Scales looks at cantharidin, the active ingredient in this famous aphrodisiac

Most Commented

Beetle behind breath test for bank notes

17 November 2014 Research

news image

Photonic crystal inks inspired by longhorn beetle could help to fight counterfeiting

Bayer wins race to buy Merck & Co consumer care

9 May 2014 Business

news image

$14bn deal will make Aspirin inventor the number two over-the-counter healthcare company